Navigation Links
Move Cautiously in Approving New Obesity Drugs, Pulmonary Hypertension Association Says
Date:6/24/2013

Silver Spring, MD (PRWEB) June 24, 2013

The American Medical Association’s decision* to regard obesity as a disease is making top headlines this week, but in fact this is not the first time American health care has taken this view, according to the Pulmonary Hypertension Association (PHA). “In the 1990s, the results for too many who took prescription treatments for obesity were disastrous, resulting in a 6-fold increase in the incidence of life-threatening pulmonary hypertension,” said PHA president Rino Aldrighetti.

Two prescription weight loss drugs – fenfluramine and dexfenfluramine (also known as Redux, Pondimin and Fen-Phen) – were pulled from the market in 1997 after they were found to be associated with heart-valve problems. These drugs also resulted in increased incidence of pulmonary hypertension, or high blood pressure in the blood vessels between the heart and lungs. In cases of PH, these vessels narrow and stiffen, requiring the heart to work too hard to pump enough oxygenated blood to the body. Patients experience shortness of breath, chest pain, fainting, fatigue, and swelling of the legs and ankles. PH can make even daily activities such as walking difficult and limits thousands of patients’ ability to work, care for their homes and families and enjoy leisure activities.

Research published in 2002 showed that patients who took fenfluramine and dexfenfluramine developed PH after taking the drug for as little as 23 days. Those on the drug more than 3 months faced a 23-fold greater risk.

“This disease caused tremendous suffering and many premature deaths which might have been prevented if the effects of these drugs had been more carefully researched and disclosed. It’s essential that we avoid making this mistake again,” Aldrighetti said. “The last ‘war on obesity’ was driven by a combination of worthy concern and marketing emphasizing profit more than health. Many patients paid the price. That story is well told by journalist Alicia Mundy who coined the term ‘Obesity Inc.’ in her book about the legal battle over Fen-Phen, Dispensing with the Truth.

“Obesity is indeed a major public health concern,” Aldrighetti said, “but we need to remember our history and temper our well-founded concern about obesity with good judgment about the overall safety of new drugs to help Americans lose weight.”

PHA recommends that all patients speak with their physicians before considering using weight loss supplements and medications. PHA also recommends that patients with PH consult with their PH specialists about the possibility of using these products.

The mission of the Pulmonary Hypertension Association is to find ways to prevent and cure pulmonary hypertension, and to provide hope for the pulmonary hypertension community through support, education, research, advocacy and awareness. To learn more about pulmonary hypertension and its effects, visit http://www.PHAssociation.org.

*http://www.ama-assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page 6/18/2013 American Medical Association

Read the full story at http://www.prweb.com/releases/2013/6/prweb10863990.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
2. Obesitys Health Costs Double Earlier Estimates
3. Troubled Homes May Fuel Obesity in Girls
4. Childhood Obesity May Raise Odds of Adult Liver Cancer
5. Could the Childhood Obesity Epidemic Be Ebbing?
6. New research finds no association between white potato consumption (baked, boiled mashed) and obesity, Type 2 diabetes or systemic inflammation
7. Mayo Clinic: Obesity epidemic fueling rise in rheumatoid arthritis among women
8. Treating childhood obesity: A family affair
9. Rising Obesity Rates Might Mean More Rheumatoid Arthritis
10. Research May Point to New Obesity Treatments
11. U.S. Obesity Rate Set to Soar, Costing Billions: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: